Two new drugs from new classes

By Megan Brodie 3 years ago | In Products
  • 3 years ago

13 October 2021 Janssen’s first lung cancer therapy RYBREVANT (amivantamab) has arrived in Australia while…

This is subscriber-only content. Please login to continue reading.